467 related articles for article (PubMed ID: 33025227)
1. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study.
Wang YJ; Chan YN; Jheng YW; Wu CJ; Lin MW; Tseng LM; Tsai YF; Liu LC
Support Care Cancer; 2021 Jun; 29(6):2959-2971. PubMed ID: 33025227
[TBL] [Abstract][Full Text] [Related]
2. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
3. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
[TBL] [Abstract][Full Text] [Related]
4. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C
Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977
[TBL] [Abstract][Full Text] [Related]
5. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.
Bao T; Basal C; Seluzicki C; Li SQ; Seidman AD; Mao JJ
Breast Cancer Res Treat; 2016 Sep; 159(2):327-33. PubMed ID: 27510185
[TBL] [Abstract][Full Text] [Related]
6. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.
Greenlee H; Crew KD; Capodice J; Awad D; Buono D; Shi Z; Jeffres A; Wyse S; Whitman W; Trivedi MS; Kalinsky K; Hershman DL
Breast Cancer Res Treat; 2016 Apr; 156(3):453-464. PubMed ID: 27013473
[TBL] [Abstract][Full Text] [Related]
7. Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.
Monfort SM; Pan X; Patrick R; Ramaswamy B; Wesolowski R; Naughton MJ; Loprinzi CL; Chaudhari AMW; Lustberg MB
Breast Cancer Res Treat; 2017 Jul; 164(1):69-77. PubMed ID: 28374323
[TBL] [Abstract][Full Text] [Related]
8. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
9. A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis.
Fontes F; Pereira S; Castro-Lopes JM; Lunet N
Breast; 2016 Oct; 29():31-8. PubMed ID: 27394676
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
[TBL] [Abstract][Full Text] [Related]
11. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.
Greenlee H; Hershman DL; Shi Z; Kwan ML; Ergas IJ; Roh JM; Kushi LH
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27794123
[TBL] [Abstract][Full Text] [Related]
12. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).
Mongiovi JM; Zirpoli GR; Cannioto R; Sucheston-Campbell LE; Hershman DL; Unger JM; Moore HCF; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Thomas Budd G; Albain KS; Ambrosone CB; McCann SE
Breast Cancer Res; 2018 Nov; 20(1):146. PubMed ID: 30486865
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants predictive of chemotherapy-induced peripheral neuropathy symptoms in gynecologic cancer survivors.
Thomaier L; Darst BF; Jewett P; Hoffmann C; Brown K; Makaram A; Blaes A; Argenta P; Teoh D; Vogel RI
Gynecol Oncol; 2021 Dec; 163(3):578-582. PubMed ID: 34674889
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing.
Zhi WI; Chen P; Kwon A; Chen C; Harte SE; Piulson L; Li S; Patil S; Mao JJ; Bao T
Breast Cancer Res Treat; 2019 Dec; 178(3):587-595. PubMed ID: 31456070
[TBL] [Abstract][Full Text] [Related]
15. Impaired Postural Control and Altered Sensory Organization During Quiet Stance Following Neurotoxic Chemotherapy: A Preliminary Study.
Monfort SM; Pan X; Loprinzi CL; Lustberg MB; Chaudhari AMW
Integr Cancer Ther; 2019; 18():1534735419828823. PubMed ID: 30741022
[TBL] [Abstract][Full Text] [Related]
16. An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy.
Andersen Hammond E; Pitz M; Steinfeld K; Lambert P; Shay B
Neurorehabil Neural Repair; 2020 Mar; 34(3):235-246. PubMed ID: 31976819
[No Abstract] [Full Text] [Related]
17. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
Kurt S; Can G
Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
[TBL] [Abstract][Full Text] [Related]
18. Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Kuroi K; Ohsumi S; Makino H; Katsumata N; Kuranami M; Suemasu K; Watanabe T; Hausheer FH
Support Care Cancer; 2012 Dec; 20(12):3355-64. PubMed ID: 22584733
[TBL] [Abstract][Full Text] [Related]
19. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.
Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J
J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868
[TBL] [Abstract][Full Text] [Related]
20. Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology.
Chen EI; Crew KD; Trivedi M; Awad D; Maurer M; Kalinsky K; Koller A; Patel P; Kim Kim J; Hershman DL
PLoS One; 2015; 10(12):e0145816. PubMed ID: 26710119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
